March 18, 2021
The Levi & Korsinsky LLP legal team representing investors in biotechnology company Illumina Inc. in their proposed shareholder class action will receive $2.1 million in attorney fees, a federal judge in San Diego said Thursday.
June 12, 2019
Biotechnology company Illumina Inc. reached a nearly $14 million deal with its investors to end securities fraud claims that it artificially inflated its stock prices by hiding declining sales from the public, according to a proposed agreement filed in California federal court Tuesday.